Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (ISRG)
NASDAQ:ISRG
Earnings Data
Report Date
Apr 21, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
2.13Last Year’s EPS
1.81Same Quarter Last Year
Strong Buy
Based on 18 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call described strong top-line and procedure growth, meaningful increases in cash flow and profitability, rapid adoption of new platforms (da Vinci 5, SP, Ion), and continued product and clinical progress. Offsetting these positives are margin pressures from tariffs and product mix, elevated operating expenses (including a large foundation donation and hiring), competitive pricing/tender dynamics in China, placement softness in Japan, and lower Ion placements in Q4. On balance the company reported multiple high-growth metrics and solid cash generation while outlining manageable but notable near-term headwinds.Company Guidance
Strong Revenue Growth
2025 revenue grew 21% year-over-year to $10.1 billion, driven by broad procedure adoption and higher recurring revenue.
Robust Procedure Volume Expansion
Total procedures grew 19% in 2025 to more than 3.1 million patients treated; da Vinci procedures grew ~18% (multiport +17%, single-port +87%) and Ion procedures grew 51%.
Geographic Procedure Strength
U.S. da Vinci procedures increased 15 to over 2 million; international procedures increased 23% to over 1.1 million, with OUS markets accounting for ~35% of global procedures.
System Placements and Platform Adoption
Placed 1,721 da Vinci systems in 2025 including 870 da Vinci 5 systems, 107 SP and 195 Ion systems; Q4 placements were 532 systems (8% YoY), with 303 da Vinci 5 placements in the quarter.
Installed Base and Utilization Gains
Total da Vinci installed base grew ~12% to just over 11,100 systems with average da Vinci utilization up 3% globally (multiport +3%, single‑port +29%, Ion +9%); da Vinci 5 installed base noted at ~1,232 systems since launch.
Strong Financial Profitability and Cash Generation
Pro forma operating margin ~37% (improved ~70 bps for the year); 2025 pro forma EPS increased 22%; free cash flow rose to $2.5 billion from $1.3 billion in 2024.
High Recurring Revenue Mix
Q4 recurring revenue grew 20% to $2.3 billion and represented 81% of total revenue, supporting revenue visibility.
Single-Port and Ion Momentum
Single-port procedures grew 87% in 2025 (installed base +39% to 377 systems) with multiple new clearances; Ion procedures grew 51% to ~144,000 procedures and installed base approached ~1,000 systems (installed base +24%).
Share Repurchases and Balance Sheet
Repurchased $2.3 billion of stock during 2025 (average price $478) and ended the year with $9.0 billion in cash and investments.
Product & Clinical Progress
Received FDA clearance for several cardiac procedures on da Vinci 5 (non-Force Feedback), continued rollout of da Vinci 5 features (Force Feedback instruments planned), new SP 510(k) clearances (e.g., nipple-sparing mastectomy) and published clinical studies showing reduced open conversion and favorable procedural economics for robotic approaches.
Guidance and Margin Outlook
2026 guidance: da Vinci procedure growth forecast 13–15%; pro forma gross profit margin guidance 67–68%; pro forma operating expense growth expected 11–15%.
ISRG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ISRG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jan 22, 2026 | $525.81 | $523.99 | -0.35% |
Oct 21, 2025 | $462.74 | $527.03 | +13.89% |
Jul 22, 2025 | $511.00 | $501.95 | -1.77% |
Apr 22, 2025 | $478.74 | $487.93 | +1.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Intuitive Surgical (ISRG) report earnings?
Intuitive Surgical (ISRG) is schdueled to report earning on Apr 21, 2026, After Close (Confirmed).
What is Intuitive Surgical (ISRG) earnings time?
Intuitive Surgical (ISRG) earnings time is at Apr 21, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ISRG EPS forecast?
ISRG EPS forecast for the fiscal quarter 2026 (Q1) is 2.13.
